James A. Robinson Jr. - 30 Nov 2021 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP

Role
Director
Signature
/s/ Stacie Aarestad, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
30 Nov 2021
Net transactions value
$0
Form type
4
Filing time
02 Dec 2021, 18:53:48 UTC
Next filing
01 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGTC Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 30 Nov 2021 Common Stock 25,000 $2.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option becomes exercisable for one third of the underlying shares on the first anniversary of the grant date, and thereafter becomes exercisable for the remaining underlying shares, in equal monthly installments over two years, resulting in the option being exercisable for 100% of the underlying shares on the third anniversary of the grant date.